News | Breast Density | November 01, 2022

Onsite Women’s Health, Whiterabbit and Washington University in St. Louis Join Forces to Explore Breast Density and Implications for Breast Cancer Risk

Onsite Women’s Health, Whiterabbit and Washington University in St. Louis Join Forces to Explore Breast Density and Implications for Breast Cancer Risk

Getty Images


November 1, 2022 —  Onsite Women’s Health, a leading national provider of breast health services, announces with Whiterabbit.ai and Washington University in St. Louis the results of a longitudinal study of breast density using artificial intelligence (AI). RSNA (Radiological Society of North America) accepted the scientific abstract submitted by researchers from Onsite, Whiterabbit and Washington University in St. Louis for an oral presentation, titled: Artificial Intelligence and Consistency in Patient Care: A Large-Scale, Longitudinal Study of Breast Density Assessment at the 108th Scientific Assembly and Annual Meeting (Date/Time of Session: 11/28/2022 1:30-2:30 pm CT). 

“Higher density breast tissue on mammograms means higher risk for breast cancer,” says Dr. Susan Holley, clinical director of Onsite Women’s Health and presenter of the abstract. “Therefore, breast density is an important variable to get right. We wanted to know if an AI tool could help us be right more often, over the long-term.” 

“We are eager to share the findings of this large-scale retrospective study as it reveals fascinating trends about the assessment of breast density over time by radiologists and our AI software, WRDensity. We believe the consistent assessment of breast density is vital to more effective patient management that moves us towards the goal of precision medicine. I’m enthusiastic that new technologies may make a difference in this noble endeavor,” says Jason Su, Whiterabbit’s co-founder and chief technology officer. “We are grateful to have been able to partner with Onsite and Washington University in St. Louis to conduct this study. Their interest in our AI tool and engagement with us has and will continue to be critical to its ongoing development.” 

The team hopes to expand upon this work to explore implications for supplemental screening, and how longitudinal changes in breast density might further inform our understanding of breast cancer risk. 

“The diversity of our research team with representation from real world practice, industry, and academic researchers allows us to pursue really exciting and clinically relevant questions,” concludes Aimilia Gastounioti, assistant professor of Radiology and director of the Breast Image Computing Lab at Washington University in St. Louis. “The advent of AI is poised to change the delivery of health care dramatically in the near future. With academic researchers, physicians and industry partners working hand-in-hand, we can bring all our strengths together to look at questions that have big implications for breast imaging and patient care.” 

For more information: http://www.onsitewomenshealth.com, 

Find more RSNA22 coverage here


Related Content

News | Ultrasound Imaging

July 1, 2025 — UPDATE: The final paper is now available at: JMIR AI - ChatGPT-4–Driven Liver Ultrasound Radiomics ...

Time July 01, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

June 26, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for the Magnetom Flow.Ace, its ...

Time June 26, 2025
arrow
News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Women's Health

June 23, 2025 — Susan G. Komen, the world’s leading breast cancer organization, recently announced it is awarding $10.8 ...

Time June 23, 2025
arrow
News | Bone Densitometry Systems

June 19, 2025 — Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered ...

Time June 18, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
Feature | Women's Health | Christine Murray

In breast cancer detection, speed and accuracy are more than clinical goals – they can significantly increase chances ...

Time June 17, 2025
arrow
News | Digital Pathology

June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to ...

Time June 12, 2025
arrow
News | Lung Imaging

June 11, 2025 — To prepare healthcare workforces and providers for an AI-driven future, Qure.ai has expanded its Global ...

Time June 11, 2025
arrow
Subscribe Now